ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Gloss, Brian ^a   Moran Jones, Kim ^a,b   Lin, Vita ^a   Gonzalez, Maria ^a   Scurry, James ^c   Hacker, Neville F ^b   Sutherland, Robert L ^a,b   Clark, Susan J ^a,b   Samimi, Goli ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Epigenetics; LincRNA; Methylation; Ovarian cancer; ZNF300; ZNF300P1

Indexed keywords

LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZNF300P1;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION ASSAY; CELL MIGRATION ASSAY; CELL POLARITY; CELL PROLIFERATION ASSAY; DNA METHYLATION; EPIGENETIC REPRESSION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; OVARY CARCINOMA; PROMOTER REGION; REGULATORY MECHANISM;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOPRECIPITATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, LONG NONCODING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84891530466     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-3     Document Type: Article

References (35)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30. 10.3322/caac.21166, 23335087.
2. Naora H. The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms. Expert Rev Mol Med 2007, 9:1-12.
3. Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 2010, 10:803-808. 10.1038/nrc2946, 20944665.
4. Kobel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, Gilks CB. Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol 2010, 29:203-211. 10.1097/PGP.0b013e3181c042b6, 20407318.
5. Landen CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 2008, 26:995-1005. 10.1200/JCO.2006.07.9970, 18195328.
6. Gloss BS, Patterson KI, Barton CA, Gonzalez M, Scurry JP, Hacker NF, Sutherland RL, O'Brien PM, Clark SJ. Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. Cancer Lett 2012, 318:76-85. 10.1016/j.canlet.2011.12.003, 22155104.
7. Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso CS, Kominsky HD, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 2011, 29:742-749. 10.1038/nbt.1914, 3152676, 21804560.
8. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076. 10.1038/nature08975, 3049919, 20393566.
9. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009, 106:11667-11672. 10.1073/pnas.0904715106, 2704857, 19571010.
10. Clark SJ. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007, 16 Spec No 1:R88-95.
11. Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010, 12:235-246. 3058354, 20173741.
12. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006, 38:540-549. 10.1038/ng1781, 16642018.
13. Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 2004, 64:3871-3877. 10.1158/0008-5472.CAN-03-3690, 15172996.
14. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010, 34:433-443. 10.1097/PAS.0b013e3181cf3d79, 2841791, 20154587.
15. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008, 109:370-376. 10.1016/j.ygyno.2008.02.006, 18395777.
16. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, Zheng SS. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011, 18:1243-1250. 10.1245/s10434-011-1581-y, 21327457.
17. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013, 32:1616-1625. 10.1038/onc.2012.193, 3484248, 22614017.
18. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041. 10.1038/sj.onc.1206928, 12970751.
19. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227. 10.1038/nature07672, 2754849, 19182780.
20. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012, 81:145-166. 10.1146/annurev-biochem-051410-092902, 3858397, 22663078.
21. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038. 10.1038/nature09144, 3206313, 20577206.
22. Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 2011, 147:1537-1550. 10.1016/j.cell.2011.11.055, 3376356, 22196729.
23. Gou D, Wang J, Gao L, Sun Y, Peng X, Huang J, Li W. Identification and functional analysis of a novel human KRAB/C2H2 zinc finger gene ZNF300. Biochim Biophys Acta 2004, 1676:203-209. 10.1016/j.bbaexp.2003.11.011, 14746915.
24. Wang T, Wang XG, Xu JH, Wu XP, Qiu HL, Yi H, Li WX. Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway. J Cell Mol Med 2012, 16:1134-1145. 10.1111/j.1582-4934.2011.01388.x, 21777376.
25. Kalari S, Jung M, Kernstine KH, Takahashi T, Pfeifer GP. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Oncogene 2012, 32:3559-3568.
26. Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012, 12:23-38.
27. Barton CA, Gloss BS, Qu W, Statham AL, Hacker NF, Sutherland RL, Clark SJ, O'Brien PM. Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival. Br J Cancer 2010, 102:87-96. 10.1038/sj.bjc.6605429, 2813742, 19935792.
28. Rosen DG, Yang G, Bast RC, Liu J. Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer. Methods Enzymol 2006, 407:660-676.
29. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M. DNA methylation: bisulphite modification and analysis. Nat Protoc 2006, 1:2353-2364. 10.1038/nprot.2006.324, 17406479.
30. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994, 22:2990-2997. 10.1093/nar/22.15.2990, 310266, 8065911.
31. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 2007, 35:e119. 10.1093/nar/gkm662, 2094090, 17855397.
32. Statham AL, Strbenac D, Coolen MW, Stirzaker C, Clark SJ, Robinson MD. Repitools: an R package for the analysis of enrichment-based epigenomic data. Bioinformatics 2010, 26:1662-1663. 10.1093/bioinformatics/btq247, 2887051, 20457667.
33. Montavon C, Gloss BS, Warton K, Barton CA, Statham AL, Scurry JP, Tabor B, Nguyen TV, Qu W, Samimi G, et al. Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecol Oncol 2012, 124:582-588. 10.1016/j.ygyno.2011.11.026, 22115852.
34. R_DevelopmentCoreTeam R: A language and environment for statistical computing. R Foundation for Statistical Computing 2010, Vienna, Austria, R_DevelopmentCoreTeam.
35. Asao T, Yazawa S, Kudo S, Takenoshita S, Nagamachi Y. A novel ex vivo method for assaying adhesion of cancer cells to the peritoneum. Cancer Lett 1994, 78:57-62. 10.1016/0304-3835(94)90031-0, 8180969.